Contact Us: 1-888-667-3325 /

Subscriber Content Preview | Request a free trialSearch  


House panel again passes bill to clip FTC's merger powers

Judiciary Committee Republicans are pushing to standardize the review process used by both antitrust agencies. Continue reading

Lawmakers told health insurance has a national component

Cigna, Humana deals could face higher antitrust hurdle if the DOJ agrees. Continue reading

In healthcare auctions, buyout firms learn new dance moves

Welsh Carson Anderson & Stowe has led the private equity pack in teaming up with strategic suitors for purchases, while Walgreens works with firms on carve-outs. Continue reading

Watching biotech grow up

Alan Mendelson talks about counseling the industry, the impact of the JOBS Act on the IPO market, and the implications of the Affordable Care Act for the sector. Continue reading

Buy and sell with Icahn and Ackman? Easier said than done

S&P's new index could let more investors get in on insurgencies, but the game has already changed. And how do you follow activists who don't want to be followed? Continue reading

Essex Woodlands invests $17.5M in AxoGen to help nerve specialist get to cash-flow positive

AxoGen shares rose 13.2% after the investment. Continue reading

Pot businesses in financial trouble face a hazy future

For the first time, an appellate court has weighed in on whether marijuana dispensaries are eligible for bankruptcy protection and if you're a debtor, the ruling is so not cool. Continue reading

Stock market volatility creates opportunities for merger arbs

Widening spreads offer bigger returns on slam-dunk deals and make risky transactions more attractive. The only worry is that financing might dry up. Continue reading

A&P sells pharmaceutical assets to Rite Aid

The Montvale, N.J., debtor wants to close the sale quickly so that customers can keep filling prescriptions. Continue reading

Small but dutiful: How to pursue change without filing

Activists with stakes below the 13D threshold can still wage successful campaigns. It's just a matter of building credibility among other shareholders. Continue reading

Nervy concentration: Health insurers cast aside caution

With consolidation already a concern, four of the five largest U.S. providers are getting together. Continue reading

FTC Commissioner Wright steps down

Surprise resignation leaves the agency leaning more Democratic. Continue reading

Meet the journalists

William Blair's Dan Shedivy sits down to talk M&A in the healthcare services sector

Middle Market healthcare deals stayed strong in 2014 but were relative ... Video

More Healthcare video

The Deal's Webcast Series

If you have not had the chance to enjoy our Webcast Series, now is the time. Join these free 60-minute discussions and get a handle on the latest strategies and tactics in private equity, cross-border and middle market dealmaking and more.

Industry Events

View information on all upcoming industry events which The Deal representatives are participating in.

The Deal Economy Event

Our senior journalists host the industry's leading forecasting event, where influential members of the deal community discuss the outlook for dealmaking.

The Deal on Twitter

Follow @TheDealNewsroom for the latest news across mergers and acquisitions, auctions, financings, restructurings and more!